By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development and global commercialization of clinical laboratory services3.25B100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States3.02B93.11%
Outside of United States223.84M6.89%